Research and development of new vaccines against infectious diseases

Am J Public Health. 2004 Nov;94(11):1931-5. doi: 10.2105/ajph.94.11.1931.


Infectious diseases are responsible for approximately 25% of global mortality, especially in children aged younger than 5 years. Much of the burden of infectious diseases could be alleviated if appropriate mechanisms could be put in place to ensure access for all children to basic vaccines, regardless of geographical location or economic status. In addition, new safe and effective vaccines should be developed for a variety of infections against which no effective preventive intervention measure is either available or practical. The public, private, and philanthropic sectors need to join forces to ensure that these new or improved vaccines are fully developed and become accessible to the populations in need as quickly as possible.

Publication types

  • Review

MeSH terms

  • Biotechnology
  • Clinical Trials as Topic
  • Global Health
  • Humans
  • Immunization Programs / organization & administration*
  • Research*
  • Vaccines*


  • Vaccines